Fenofibrate-induced acute renal failure due to massive rhabdomyolysis after coadministration of statin in two patients

Internal Medicine

Volumn 47, Issue 11, 2008, Pages 1017-1019

  Unal, Aydin ^a   Torun, Edip ^a   Sipahioglu, Murat Hayri ^a   Tokgoz, Bulent ^a   Kaya, Mehmet Gungor ^a   Oymak, Oktay ^a   Utas, Cengiz ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Acute renal failure; Fenofibrate; Rhabdomyolysis; Statin

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE KINASE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENOFIBRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MANNITOL; NITROGEN; PRAVASTATIN; UREA; ANTILIPEMIC AGENT;

ACUTE KIDNEY FAILURE; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; COMBINATION CHEMOTHERAPY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DIURESIS; DRUG WITHDRAWAL; FEMALE; FLUID RESUSCITATION; HEMODIALYSIS; HEMOGLOBINURIA; HOSPITAL ADMISSION; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; KIDNEY FUNCTION; MALE; METABOLIC ACIDOSIS; MONOTHERAPY; OLIGURIA; RHABDOMYOLYSIS; UREA NITROGEN BLOOD LEVEL; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; DRUG INTERACTION; MIDDLE AGED;

ANTILIPEMIC AGENTS; CORONARY ARTERY DISEASE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; PROCETOFEN; RHABDOMYOLYSIS;

EID: 48249131250     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0939     Document Type: Article

References (16)

1. Singh D, Chander V, Chopra K. Rhabdomyolysis. Methods Find Exp Clin Pharmacol 27: 39-48, 2005.
2. Polderman KH. Acute renal failure and rhabdomyolysis. Int J Artif Organs 27: 1030-1033, 2004.
3. Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore) 84: 377-385, 2005.
4. Barker BJ, Goodenough RR, Falko JM. Fenofibrate monotherapy induced rhabdomyolysis. Diabetes Care 26: 2482-2483, 2003.
5. Archambeaud-Mouveroux F, Lopez S, Combes C, et al. Rhabdomyolysis induced by fenofibrate monotherapy. Rev Med Interne 27: 573-574, 2006.
6. Yang KC, Fang CC, Su TC, Lee YT. Treatment of fibrate-induced rhabdomyolysis with plasma exchange in ESRD. Am J Kidney Dis 45: 57-60, 2005.
7. Ireland JH, Eggert CH, Arendt CJ, Williams AW. Rhabdomyolysis with cardiac involvement and acute renal failure in a patient taking rosuvastatin and fenofibrate. Ann Intern Med 142: 949-950, 2005.
8. Sgro C, Escousse A. Side effects of fibrates (except liver and muscle). Therapie 46: 351-354, 1991 (in French).
9. Graham DJ, Staffa JA, Shatin D, et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 292: 2585-2590, 2004.
10. Kursat S, Alici T, Colak HB. A case of rhabdomyolysis induced acute renal failure secondary to statin-fibrate-derivative combination and occult hypothyroidism. Clin Nephrol 64: 391-393, 2005.
11. Schech S, Graham D, Staffa J, et al. Risk factors for statin-associated rhabdomyolysis. Pharmacoepidemiol Drug Saf 16: 352-358, 2007.
12. Clouatre Y, Leblanc M, Ouimet D, Pichette V. Fenofibrate-induced rhabdomyolysis in two dialysis patients with hypothyroidism. Nephrol Dial Transplant 14: 1047-1048, 1999.
13. Fauchais AL, Iba Ba J, Maurage P, et al. Polymyositis induced or associated with lipid-lowering drugs: five cases. Rev Med Interne 25: 294-298, 2004 (in French).
14. Schmidt GA, Hoehns JD, Purcell JL, Friedman RL, Elhawi Y. Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin, amiodarone, and atazanavir. J Am Board Fam Med 20: 411-416, 2007.
15. Ricaurte B, Guirguis A, Taylor HC, Zabriskie D. Simvastatin-amiodarone interaction resulting in rhabdomyolysis, azotemia, and possible hepatotoxicity. Ann Pharmacother 40: 753-757, 2006.
16. Ballantyne CM, Corsini A, Davidson MH, et al. Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med 163: 553-564, 2003.